This study looked at add-on treatment with perampanel in very young children with drug-resistant epilepsy.
Researchers studied 3 families with epilepsy from a highly consanguineous population.
This paper was a systematic review, which means the authors searched past medical reports and retrospective case series to look for patterns.
This study tested ES-481, a new add-on anti-seizure medicine, in adults with drug-resistant epilepsy.
Researchers combined results from randomized, double-blind studies that tested two add-on seizure medicines, lacosamide (LCM) and brivaracetam (BRV), in adults and older teens with drug-resistant focal epilepsy.
This report describes one premature newborn boy in the Netherlands who had hard-to-control seizures.
This paper was a structured narrative review, not a new clinical trial.
This paper describes the Urgent Epileptic Seizures Care Process in the Community of Madrid for severe epileptic seizures, also called the “Seizure Code.” It is intended for both children and adults.
This paper combined results from earlier studies to look for factors linked with response to vagus nerve stimulation (VNS) in people with drug-resistant epilepsy.